POSTERS ASCO 2024

Cáncer gastrointestinal

Gastroesofágico, pancreático y hepatobiliar

VIRAGE: A phase IIb, open-label, randomized study of nab-paclitaxel and gemcitabine plus/minus VCN-01 in patients with metastatic pancreatic cancer.

VIRAGE: A phase IIb, open-label, randomized study of nab-paclitaxel and gemcitabine plus/minus VCN-01 in patients with metastatic pancreatic cancer.

Abstract: TPS4210 Poster Bd #: 175a

Poster

Descargar

Autor
Rocío García-Carbonero, MD, PhD

Medical Oncology Department. Hospital Universitario 12 de Octubre, Imas12, UCM

Compartir:

Una iniciativa científica de:

eco clover

Con el patrocinio de:

REGENERON